ANKELIFE

ANKELIFE specializes in the research, development, and production of genetic engineering drugs in the cosmetics field.

Last Funding Type: Series A
Last Funding Money Raised: ¥10M
Industries: Biotechnology,Cosmetics,Health Care,Pharmaceutical,Product Research
Founded date: Mar 28, 2014
Number Of Employee: 1 - 10
Operating Status: Active

Number of Funding Rounds

Total Funding Amount

3

¥33M

ANKELIFE has raised a total of ¥33M in funding over 2 rounds. Their latest funding was raised on Aug 2, 2017 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 2, 2017	Series B	¥20M	1	Hefei Hi-Tech Venture Capital	—	Detail
Oct 14, 2016	Series A	¥10M	1	Zhongan Health	—	Detail
Oct 27, 2015	Angel	¥3M	1	—	—	Detail

Number of Lead Investors

Number of Investors

2

3

ANKELIFE is funded by 3 investors. Hefei Hi-Tech Venture Capital and Zhongan Health are the most recent investors.

Investor Name	Lead Investor	Funding Round
Hefei Hi-Tech Venture Capital	Yes	Series B
Zhongan Health	Yes	Series A
Hefei Ke Chuang	—	Angel